Key result
KCNMA1 variants N999S and D434G increase mouse seizures, whereas H444Q shows loss of function.
Why the study?
The relevance of KCNMA1 mutations and the basis for clinical heterogeneity in paroxysmal non-kinesigenic dyskinesia with or without epilepsy (PNKD3) had not been established.
The study establishes the relative pathogenic potential of KCNMA1 patient alleles (N999S > D434G > H444Q) and validates Kcnma1 N999S/WT mice as a model for PNKD3.
No immediate clinical implications; hypothesis-generating for KCNMA1 variant effects in human neurological disorders.
KCNMA1 forms the pore of BK K + channels, which regulate neuronal and muscle excitability. Recently, genetic screening identified heterozygous KCNMA1 variants in a subset of patients with debilitating paroxysmal non-kinesigenic dyskinesia, presenting with or without epilepsy (PNKD3). However, the relevance of KCNMA1 mutations and the basis for clinical heterogeneity in PNKD3 has not been established. Here we evaluate the relative severity of three KCNMA1 patient variants in BK channels, neurons, and mice. In heterologous cells, BK N999S and BK D434G channels displayed gain-of-function (GOF) properties, whereas BK H444Q channels showed loss-of-function (LOF) properties. The relative degree of channel activity was BK N999S > BK D434G > WT > BK H444Q . BK currents and action potential firing were increased, and seizure thresholds decreased, in Kcnma1 N999S/WT and Kcnma1 D434G/WT transgenic mice but not Kcnma1 H444Q/WT mice. In a novel behavioral test for paroxysmal dyskinesia, the more severely affected Kcnma1 N999S/WT mice became immobile after stress, consistent with stress-induced immobility episodes observed in PNKD3-affected individuals. Homozygous Kcnma1 D434G/D434G mice showed similar immobility, but in contrast, homozygous Kcnma1 H444Q/H444Q mice displayed hyperkinetic behavior. These data establish the relative pathogenic potential of patient alleles as N999S > D434G > H444Q and validate Kcnma1 N999S/WT mice as a model for PNKD3 with increased seizure propensity.
No takes yet. Share an insight, caveat, or question.
Park et al. (2022) studied Paroxysmal non-kinesigenic dyskinesia (PNKD3). KCNMA1 variants (N999S, D434G, H444Q) vs. Wild-type (WT) was evaluated on Channel properties, action potential firing, seizure thresholds, and behavioral phenotypes. KCNMA1 patient variants N999S and D434G displayed gain-of-function properties with increased seizure propensity and stress-induced immobility in mice, whereas H444Q showed loss-of-function properties.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: